Pediatricians should refer patients to a pediatric subspecialist to identify candidates for biologic therapy and select the appropriate medication
U.S. Spending Up for Cancer Drugs Lacking Evidence of Survival Benefit
From 2017 to 2019, Medicare spending on 10 accelerated approval drugs with lack of overall survival benefit increased to $569 million
Inbox Time Linked to Reduced Odds of Physician Turnover
And increase in mean total messages received per day seen for physicians during March 2020 to June 2021
FDA Warns Against Using At-Home Dermal Filler ‘Pens’
Serious adverse events have been reported in connection with dermal filler use, such as permanent damage to the skin, lips, and eyes
Lyme Disease Often Diagnosed Later Among Black Patients
Differences in the recognition of the manifestations of Lyme disease by physicians or by patients may contribute to later diagnosis
Skin Cancer App Fails to Identify Rare, Aggressive Cancers
Sensitivity and specificity for detecting Merkel cell carcinoma and amelanotic melanoma was 79.4 and 37.7 percent, respectively
Nonmelanoma Skin Cancers Larger Among Hispanic Patients
Mohs micrographic surgery defect sizes larger for Hispanic/Latino patients than for non-Hispanic White patients
Former FDA Chief Robert Califf a Contender to Head Agency Again
FDA has not had a permanent head for more than eight months, is being overseen by Acting Commissioner Janet Woodcock
Climate Change Is World’s Most Pressing Health Problem: WHO
WHO report and open letter signed by health professionals outline major climate issues affecting public health
Infection Risk Does Not Seem to Differ Among Biologics for Psoriasis
Differential risk for serious infection or respiratory tract infection, including SARS-CoV-2, not seen among biologics used to treat psoriasis